AGM Statement

Summary by AI BETAClose X

Volex plc has reported a strong start to FY2027, with constant currency organic revenue growth of 28.0% in the four months to July 2026, driven by broad-based demand across all five end-markets, particularly Complex Industrial Technology and EV & Electrification. The company expects its full-year underlying operating profit to exceed market expectations, which currently forecast an average of $138.3 million on revenue of $1,338 million. This positive outlook is supported by managed operating expenses, improved operating leverage, and the recent completion of the KST acquisition, which enhances the Group's medical offering and operating margin. Volex also successfully completed its move to the Main Market of the London Stock Exchange on 24 July 2026.

Disclaimer*

Volex PLC
25 August 2026
 

Description: Volex Logo Black

 

 

25 August 2026

Volex plc

("Volex", the "Company", or the "Group")

AGM Statement

 

Very strong start to FY2027 with profit expected to be ahead of market expectations

 

Volex plc (LSE: VLX), the specialist integrated manufacturer of critical power and data transmission products, is pleased to report a trading update for the four months ended 31 July 2026, ahead of the Company's annual general meeting, being held at 2.00 pm today.

 

Broad-based trading momentum

Volex has made a very strong start to the new financial year, delivering 28.0% constant currency organic revenue growth year on year in the four months to July 2026. Growth was broad-based across all five end-markets, led by Complex Industrial Technology, where Data Centre customer demand has been sustained at the elevated exit rate of FY2026, and by increased demand for EV & Electrification products, supported by continued electrification trends and customer focus on energy efficiency. Good growth was also delivered in Consumer Electricals, Off-Highway and Medical.

The 28.0% year-on-year rate partly reflects a prior-year comparator in which revenue built progressively as new Data Centre programmes ramped up, and headline year-on-year growth rates are therefore expected to normalise over the remainder of the year as this effect annualises. Sequential trading is the better guide to underlying momentum, with average monthly revenue in the first four months of the year running 8% higher than the monthly average for the second half of FY2026.

Operating expenses continue to be managed closely, with efficiency savings and enhanced operating leverage supporting improved underlying operating margin performance, in line with the Group's medium-term strategic plan.

KST acquisition completed

The acquisition of the remaining interest in Kepler SignalTek ('KST') completed during the period. Integration is progressing in line with plan, extending the Group's medical offering into patient-to-device applications and enhancing the Group's underlying operating margin.

Main Market

On 24 July 2026, the Group's shares were admitted to the Official List and to trading on the Main Market of the London Stock Exchange, completing the move from AIM. The Board believes the move better reflects the Group's scale and maturity and will broaden the range of potential investors in the Company.

Outlook

As a result of the strength of trading in the opening months and the operating leverage inherent within the business model, the Board now expects FY2027 underlying operating profit1 to be ahead of current market expectations2.

The Group remains well positioned to make further progress against the medium-term strategic plan set out at our Capital Markets Day in April.

1 Underlying operating profit is before adjusting items which are one-off in nature and significant (such as restructuring costs, impairment charges or acquisition-related costs), the amortisation and impairment of acquired intangible assets and share-based payment charges. This trading update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement.

2 As at 24 August 2026, company compiled consensus of analysts' forecasts for the year ending 31 March 2027, based on the forecasts of 5 of the 7 analysts covering the Company (excluding forecasts not yet updated to reflect the acquisition of KST), shows an average forecast for revenue of $1,338 million, with a range of $1,327 million to $1,347 million, and an average forecast for underlying operating profit of $138.3 million, with a range of $135.3 million to $141.3 million.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

For further information please contact:

Volex plc                                                                                                  +44 (0) 1256 442570

Nat Rothschild, Chief Executive Officer                                             investor.relations@volex.com

Jon Boaden, Chief Financial Officer

                        

Peel Hunt LLP - Joint Broker                                                              +44 (0) 20 7418 8900

Ed Allsopp

Dom Convey

Tom Graham

 

Jefferies - Joint Broker                                                                        +44 (0) 20 7029 8000

Philip Noblet
Sam Barnett

Harry Le May

Sodali & Co. - Media Enquiries                                                           +44 (0) 20 7250 1446

James White
Peter Lambie
James Whitaker

About Volex plc

Volex plc (LSE: VLX) is a specialist integrated manufacturer of critical power and data transmission products. The Group serves international blue-chip customers in five end-markets: Complex Industrial Technology, Consumer Electricals, EV & Electrification, Medical and Off-Highway. Headquartered in the UK, Volex operates 23 manufacturing sites with a presence in 25 countries and employs approximately 12,500 people. Its products are supplied to Original Equipment Manufacturers and Electronic Manufacturing Services companies worldwide. Learn more at www.volex.com.

Forward looking statements

This announcement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the announcement. Forward-looking statements should be regarded with caution as, by their nature, such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Volex (VLX)
UK 100

Latest directors dealings